Breaking AI & Tech News Analyzed

The conflict between Iran, the US, and Israel has taken a severe turn with a series of coordinated attacks on Iranian universities and infrastructure. A research center at Shahid Beheshti University in Tehran was recently bombed, leaving it in ruins. This attack is part of a larger pattern of civilian sites being targeted by the US and Israel. Over 30 universities have been impacted since the start of the war on February 28, according to Hossein Simaei Saraf, the Iranian minister of science, research, and technology. The attacks have not only damaged educational facilities but also research centers, including those working on domestically made satellites and infectious diseases. The Pasteur Institute in Tehran, a renowned center for vaccine development and biological products, was also attacked, sustaining significant damage and disrupting health services. The World Health Organization (WHO) confirmed the damage and noted that no casualties were reported. In addition to educational and healthcare facilities, over 20 healthcare facilities have been targeted since March 1, according to WHO Director-General Tedros Adhanom Ghebreyesus. The attacks have also affected schools, houses, and businesses, resulting in over 2,000 deaths and widespread destruction. The economic sector has not been spared, with petrochemical and steel factories being destroyed in recent bombardments. The US and Israel have also targeted critical infrastructure, including power plants and water desalination plants, which are civilian targets protected under international law. The Iranian government and the Islamic Revolutionary Guard Corps (IRGC) have vowed to retaliate and escalate attacks across the region. The situation has drawn international condemnation, with over 100 US legal experts expressing concerns about potential war crimes and violations of international humanitarian law.

Martin Ho arrived at Tottenham in July, inheriting a side that had slumped to 11th place the previous season. Within months the club has risen to fifth in the Women's Super League, just three points shy of matching their record 32‑point tally from 2021‑22. With three league games remaining, Spurs are set to face Chelsea in an FA Cup quarter‑final, while a recent League Cup exit saw them lose 2‑1 to Manchester United. Ho, who began coaching at 17 after an unfulfilled stint at Everton’s academy, describes the campaign as a success so far, noting the progress from a “rudderless” squad to a more cohesive unit. He acknowledges the boldness of such a claim before the season ends, especially after consecutive 5‑2 defeats to Manchester City and Arsenal, but stresses that the club’s trajectory is positive. Only two new signings – Norway forward Cathinka Tandberg and Japan defender Toko Koga – joined the roster in the summer, a deliberate move by Ho to assess the existing squad first. "I needed to see the players with my own eyes and apply my coaching methodology," he explained. Ho’s approach draws on his experience as an assistant at Manchester United under Casey Stoney and Marc Skinner, and his earlier head‑coach role at Norwegian side SK Brann. He spent time learning the club’s culture, fanbase and values before implementing changes. Key to the transformation was a psychological reset. Ho told his players that the team must look forward and abandon the disappointment of the previous season. "We asked them to play bravely, press higher and accept that mistakes are part of growth," he said. The 5‑1 loss to Manchester City early in the season became a catalyst. Ho observed that the squad’s response demonstrated a shift in mentality, prompting him to reinforce belief and challenge the players to improve. Consistency has been elusive – three wins from eight league matches – but the side has shown signs of potential, and January brought additional reinforcements. Looking ahead, Ho warns against over‑inflated expectations. "If we promise Champions League football now and fail, it harms everyone," he cautioned, noting that European competition would be premature for a club still building its foundation. He emphasizes the need for steady, sustainable progress rather than a flash‑in‑the‑pan surge. "We must evolve the squad, staff, processes and investment together," Ho said. With a limited pool of elite talent, attracting and retaining players remains a challenge. Ho stresses creating an authentic environment that offers clear development pathways, saying, "When players see their value and a clear route forward, they stay and improve." Born in Liverpool to a Chinese father and English mother, Ho credits his upbringing for his holistic coaching philosophy. He often remarks that coaches are like thieves, constantly borrowing ideas from one another, and strives to adapt those influences into a style that reflects his own vision for Tottenham Women.

The deployment of reflective mirrors on satellites and the launch of thousands more satellites into low Earth orbit could have significant consequences for human health and ecosystems. Leading sleep and circadian rhythm researchers have raised concerns about the potential disruption to natural night-time light environments.The US Federal Communications Commission (FCC) is considering plans by Reflect Orbital to illuminate parts of the Earth at night using reflective satellites, as well as applications from SpaceX that could dramatically expand satellite numbers in low Earth orbit.2,500 researchers from over 30 countries have expressed concerns that altering the light-dark cycle could disrupt biological clocks that regulate sleep and hormone secretion in humans and animals, migration in nocturnal species, seasonal cycles in plants, and the rhythms of marine phytoplankton.Prof Charalambos Kyriacou, president of the European Biological Rhythms Society (EBRS), emphasized that "plants need the night" and that eliminating it could have global implications for food security.Reflect Orbital aims to use satellites equipped with large reflective mirrors to redirect sunlight onto areas roughly 5km to 6km wide "on demand", with brightness adjustable "from full moon to full noon".Meanwhile, SpaceX has proposed launching up to 1m satellites to create a giant solar-powered computing network in orbit designed to run artificial-intelligence workloads.Ruskin Hartley, chief executive of DarkSky International, noted that scientific studies have already shown that the existing number of satellites in orbit has increased diffuse night sky brightness by roughly 10%.Experts warn that if current trends in satellite launches and debris generation continue, night sky brightness could increase substantially over the coming decade, approaching the threshold astronomers have set for preserving naturally dark skies.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The UK medicines regulator has opened an inquiry into a growing number of clinics that sell injectable peptides while promoting them as cures for everything from ageing to injury recovery. The investigation, disclosed by the Guardian, focuses on whether these businesses are breaching the Human Medicines Regulations 2012 by making unauthorised medicinal claims. Interest in peptide‑based treatments has surged in recent years, driven by social‑media influencers, some healthcare professionals, and direct‑to‑consumer marketers. Yet the scientific foundation for most of these claims is weak, with the bulk of research confined to animal models or cell‑culture studies. According to an MHRA spokesperson, any clinic that advertises a peptide as having therapeutic benefits must treat the product as a medicine, which triggers a comprehensive regulatory framework. "If clinics offering peptide injections make medicinal claims for those treatments, the products will be considered medicines and subject to regulation," the agency warned, adding that it will act against any identified breaches. Guardian reporters identified several high‑ranking Google search results that list peptides such as Cortexin (promoted for neuroprotection), BPC‑157 (claimed to aid tissue repair), and Thymosin Alpha (advertised to boost immunity). After being contacted, one clinic removed the statements from its website. Another clinic, while acknowledging the limited human evidence, continued to market seven specific peptides, providing price lists (£350 per month for a single peptide, £450 for two) and offering delivery via vials, syringes, or pre‑filled pens for an additional fee. During a free consultation, a clinician highlighted the experimental nature of the products, noting the absence of large‑scale, randomised clinical trials and recommending a break of four to eight weeks between treatment cycles to mitigate unknown risks. The clinician suggested BPC‑157 for post‑exercise recovery, describing it as a facilitator of cellular repair and blood flow, but warned against its use in smokers or individuals with a family history of cancer due to potential angiogenic effects. The second peptide discussed was MOTS‑C, portrayed as a mitochondrial enhancer that could improve stress resilience, lower insulin resistance, and reduce visceral fat by boosting cellular energy production (ATP). The MHRA confirmed it is reviewing whether the clinician’s statements constitute medicinal claims. The clinic defended its approach, emphasizing that it clearly informs clients that the peptides are not licensed medicines and that the evidence base is largely pre‑clinical. In a broader statement, Lynda Scammell, head of borderline products at the MHRA, explained that peptide products may be marketed as cosmetics, supplements, or medicines, and each case is assessed on its intended use, pharmacological effect, and supporting evidence. She added, "We disregard claims that products are for ‘research purposes’ if it is clear that such claims are being used as an attempt to avoid medicines regulations." Peptides are short chains of amino acids, some of which occur naturally (e.g., insulin). While synthetic peptide analogues like semaglutide and tirzepatide have secured approval for weight‑loss treatments, many of the compounds promoted by these clinics remain experimental and lack the rigorous safety and efficacy testing required for medicinal products.

As the 2026 local and regional elections draw nearer, the spectre of Trussonomics looms large over the British political landscape. From the Conservatives to the Greens, parties are unveiling extravagant fiscal promises that they claim can be funded by cuts elsewhere or additional borrowing, while insisting the broader economy will remain unharmed. Critics warn that any adverse effects will inevitably be shifted onto people and businesses outside the parties' core constituencies, effectively socialising the risk. Only Keir Starmer and his Labour cabinet appear to resist the pressure to re‑engineer the economy without acknowledging inevitable spill‑overs or extra costs. Former Prime Minister Liz Truss famously pledged £45 bn of tax cuts, financed through extra borrowing and so‑called welfare “efficiencies”. The plan was pitched as a catalyst for an entrepreneurial surge that would lift the UK out of a prolonged period of low productivity. Heading into May’s local polls, the Conservatives are touting a new “big‑spending” agenda after recent welfare cuts, highlighted by a headline pledge to shrink the welfare bill by £23 bn. Shadow Chancellor Mel Stride declared that the “culture of ‘something for nothing’ must end, now”. Green Party leader Zack Polanski has softened some of his party’s more radical proposals, yet the manifesto remains vague. Earlier drafts featured a litany of “free lunches”, signalling an ambition to raise taxes by **more than £170 bn a year** by the end of the next parliament. Key components of the Green plan include a £90 bn annual carbon tax and a matching increase in day‑to‑day public spending, alongside a proposed £90 bn boost to the capital‑spending budget (raising it from £160 bn to £250 bn per year). Reform UK has embraced Trussonomics with gusto, promising to raise the income‑tax threshold from £12,570 to £20,000 – a move that would cost the exchequer **over £40 bn each year**. Underlying many of these pledges is a belief that the UK can reverse a century of economic decline with a “magician’s wand”, ignoring potential repercussions for financial markets, trading partners, and a rapidly disintegrating global order. While the article briefly references the United States and France, the French electorate’s recent rejection of similarly flamboyant policies in local elections serves as a cautionary tale: voters in key cities like Paris and Marseille opted for centrist candidates over the radical platforms of Marine Le Pen’s National Rally and Jean‑Luc Mélenchon’s LFI. The broader context is a decade marked by two major wars, a quantum technological shift, and accelerating climate change – none of which offer quick‑fix solutions. Labour’s economic strategy, championed by Rachel Reeves, hinges on an early‑parliament spending surge intended to generate growth before the next general election. However, the damage inflicted by the previous government is still being reassessed, with the public‑finance gap now appearing larger than the £22 bn initially highlighted by Reeves. Labour still holds considerable funds earmarked for investment, but bureaucratic inertia in Whitehall hampers swift action, and Starmer bears responsibility for this paralysis. Demonstrating tangible returns on public spending – with HS2 currently the sole benchmark – could justify future tax increases on higher earners, provided the money is not wasted. In an uncertain world, the article argues that rational, evidence‑based governance is preferable to “outlandish initiatives” that create a multitude of losers. Ultimately, the piece concludes that Truss’s experiment was a disaster not merely because of the misguided belief that tax cuts can drive sustainable growth in a mature economy, but because it relied on an imagined “escape hatch” to propel the UK to a higher economic plane.

Leeds United travel to West Ham for an FA Cup quarter‑final that both clubs would prefer to avoid, yet manager Daniel Farke is clear about his priorities. With an MA in economics and a diploma in sporting directorship, he stresses that Premier League survival is the club’s "bread and butter" and must come first.Off the pitch, the German‑born coach unwinds by immersing himself in literary fiction, counting Gabriel García Márquez’s One Hundred Years of Solitude among his favourites.Farke’s dual role as a tactician and a storyteller raises the question of whether he can engineer a season that delivers both survival and cup glory. A successful double could make it hard for the Elland Road hierarchy to deny him the new contract he desires."I’m a big believer in cup competitions," Farke said, emphasizing that Leeds will approach the West Ham tie "very, very seriously". He added that the squad will start strong unless a player shows a physical issue, in which case they will be protected.The risk of fielding a first‑choice XI against a relegation rival mirrors the 2013 Wigan experience, when the club won the FA Cup but suffered relegation three days later – a bittersweet double that highlighted the fine line between triumph and disaster.Leeds have failed to win any of their last six Premier League matches, drawing four, a run that has stalled momentum. A victory could act as a catalyst to change the narrative as the season draws to a close.Injury concerns loom over striker Dominic Calvert‑Lewin, who is undergoing a hamstring scan. The England international, who netted seven goals in six games at the end of 2025, has managed only two league goals this season. A fit Calvert‑Lewin could revive Leeds’ hopes of reaching their first FA Cup semi‑final since 1987 and keep his World Cup aspirations alive.The goalkeeping position also remains unsettled. After losing his starting spot to Karl Darlow, Lucas Perri has featured solely in the FA Cup this year, leaving the decision on who starts for the West Ham tie open.Financial pressures add urgency to Farke’s decisions. Leeds’ latest accounts reveal a £49.2 million pre‑tax loss for the year ending June 2025, and a costly stadium expansion project that would be jeopardised by relegation. This backdrop explains the psychological blow of a 1‑0 loss to an under‑strength Sunderland side earlier in the month.Farke believes a deep FA Cup run could erase lingering self‑doubt. "If we secure Premier League survival and go further in the FA Cup, we can write a special chapter for this club," he said, urging his squad to seize the chance to make history.

AI‑Driven Power Race The AI boom is prompting the biggest wave of power‑infrastructure investment since the early days of cloud computing. Companies are scrambling to lock in natural‑gas supplies and build on‑site generators, a move that could reshape electricity markets in the southern United States. Scale of the Projects Microsoft is partnering with Chevron and Engine No. 1 to construct a natural‑gas plant in West Texas that could reach 5 GW of capacity. Google has confirmed a collaboration with Crusoe for a 933 MW plant in North Texas. Meta is adding seven more plants to its Hyperion data‑center complex in Louisiana, bringing total on‑site capacity to 7.46 GW—enough, the company notes, to power the entire state of South Dakota. Combined, these projects exceed 13 GW, roughly equivalent to the average electricity demand of a mid‑size U.S. state. Supply Constraints and Cost Pressures Wood Mackenzie warns that turbine prices have surged 195% versus 2019 levels. If a 2020 turbine cost $1 million, the same unit now costs about $2.95 million, inflating the equipment share of a plant’s budget from 20% to up to 30%. The consultancy also notes a six‑year lead time for turbine delivery, meaning new orders cannot be placed until 2028. This bottleneck could delay the rollout of additional capacity precisely when AI workloads are accelerating. Resource Availability and Market Risks The U.S. Geological Survey estimates that a single gas‑rich region holds enough supply to power the entire United States for 10 months. While abundant, production growth in the three leading shale basins—responsible for three‑quarters of U.S. output—has slowed, tightening the long‑term outlook. Natural gas accounts for about 40% of U.S. electricity generation (EIA). Consequently, any spike in gas prices reverberates through wholesale electricity markets, raising the cost of power for all consumers, not just data‑center operators. Strategic Risks for Tech Companies Behind‑the‑meter gas plants allow firms to claim “self‑supply,” but they merely shift demand from the public grid to the gas grid, potentially driving up wholesale gas prices. Industrial users—petrochemical plants, fertilizer manufacturers—cannot easily substitute gas with renewables, so they may push back against large‑scale data‑center consumption. Extreme weather, such as the 2021 Texas freeze, can curtail wellhead output, forcing a choice between keeping AI workloads online or supplying heat to households. In sum, the AI‑driven rush for natural‑gas power plants highlights a fundamental physical constraint: the digital economy still depends on finite, market‑sensitive energy resources. Betting heavily on a commodity that can swing dramatically in price may prove costly if AI growth plateaus or if gas supply tightens.

Iranian footballer Mona Hamoudi had one ambition when she boarded the flight to Australia for the Women’s Asian Cup: to play well. However, the tournament became a test of her skills, patience, and ability to make difficult decisions under enormous pressure.Hamoudi, a 32-year-old midfielder, was part of the Iranian national squad that travelled to Australia in early March. The trip unravelled into one of the most scrutinised episodes in the history of Iranian women’s sport. The squad had remained silent during the national anthem ahead of their Asia Cup opener against South Korea on March 2, two days after the United States and Israel went to war with Iran and killed Supreme Leader Ayatollah Ali Khamenei.Their silence was perceived by some as a protest against the Iranian government, and Iran’s state television branded the women as “traitors”. The players sang the anthem at their next two matches, but fears for their safety grew further after it was reported in the media that they were being monitored by Iranian government and football officials.Following Iran’s elimination at the group stage, five players – Hamoudi among them – claimed asylum and were granted humanitarian visas by the Australian authorities. However, after the rest of the squad left Australia on March 10, five of the seven later reversed course and said they would return to Iran – including Hamoudi.Hamoudi and teammate Zahra Sarbali describe the decision to return to Iran as inseparable from a sense of duty; to family, teammates, and “national obligation”, rather than a purely free choice made in calm and safety. They faced harassment and constant following from media and social media, and the expectations and pressure from the Iranian-Australian community.The journey back to Tehran was marked by fear and tension, with the media attention that had followed them throughout the tournament only intensifying once they were back in Iran. The football federation offered formal support, and the players appeared on national television after their return and resumed training as normal.On March 19, the team were met in Tehran with a hero’s welcome from the public, with several thousand people gathering in Valiasr Square, many holding Iranian flags. However, fears remain over the consequences for their careers and how their every future action might be interpreted.Maryam Irandoust, a former head coach of the Iranian women’s national team, said these experiences will carry a psychological weight onto the pitch, directly affecting performances in training and in matches. Adel Ferdosipour, a veteran Iranian sports journalist, warned that any punishment of the players could deter future footballers from representing Iran.